多只创新药概念股近期获机构扎堆调研

Group 1 - The average stock price of over 80 innovative drug concept stocks has increased by 4.42% since August [1] - Notable gainers include Nanmo Bio, Shenlian Bio, Guangshengtang, and Yangguang Nuohuo, all of which have risen over 40% during the month [1] - Six concept stocks, including Borui Pharmaceutical, Anke Bio, Jiuzhou Pharmaceutical, and Yifan Pharmaceutical, have received research from more than 10 institutions [1] Group 2 - More than half of the innovative drug concept stocks have experienced net capital inflow since August [1] - Leading companies in terms of net capital inflow include WuXi AppTec, Borui Pharmaceutical, Hanyu Pharmaceutical, Ganli Pharmaceutical, and Kanglong Chemical, each exceeding 200 million [1]